The ASCO Post Podcast

Latest Episodes:

Intensified Preoperative Therapy for Patients With Newly Diagnosed Locally Advanced Rectal Cancer Apr 30, 2021

Show notes

This week, we’ll discuss the findings of a trial that examined the efficacy of intensified therapy for patients with newly diagnosed locally advanced rectal cancer. Then, we’ll talk about the FDA’s approval of a new agent for advanced endometrial cancer.

Coverage of stories discussed this week on ascopost.com:

Addition of Neoadjuvant FOLFIRINOX to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer

FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Endometrial Cancer

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Short-Term Safety of the COVID-19 Vaccine in Patients With Cancer Receiving Immunotherapy Apr 26, 2021

Show notes

This week, we review data on the short-term safety of the COVID-19 vaccine in patients with cancer receiving immunotherapy. We’ll also discuss a study of the monoclonal antibody tislelizumab plus chemotherapy as first-line treatment for patients with advanced squamous non–small cell lung cancer.

Coverage of stories discussed this week on ascopost.com:

Short-Term Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients Receiving Immunotherapy

First-Line Tislelizumab Plus Chemotherapy vs Chemotherapy Alone in Advanced Squamous NSCLC

To listen to more podcasts from ASCO, visit asco.org/podcasts.

More News From the AACR Annual Meeting: Cancer Biology, Brain Metastases, and Diet Apr 19, 2021

Show notes

On this week’s podcast, we’re continuing our coverage of the 2021 AACR Annual Meeting. We’ll hear from researchers on the role of cancer biology in treatment paradigms; novel strategies in the care of patients with brain metastases; and the influence of diet on cancer development and response to therapy.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

News From the AACR Annual Meeting: NSCLC, Lymphoma, and Uveal Melanoma Apr 12, 2021

Show notes

The 2021 AACR Annual Meeting launched week 1 of a two-week program on April 10 featuring plenary sessions and major scientific symposia. Week 2 will take place in May. In this week’s podcast, The ASCO Post speaks with faculty at AACR’s annual meeting who presented clinical research in non–small cell lung cancer, non-Hodgkin lymphoma, and uveal melanoma.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Differences in Disease Between Younger and Older Women With Breast Cancer Apr 02, 2021

Show notes

This week, we’ll be discussing a recent presentation that parsed out differences in disease seen in younger vs older women with breast cancer. We’ll also hear about an update to the NCCN Guidelines for triple-negative breast cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

More From SGO: News in Ovarian and Cervical Cancers Mar 26, 2021

Show notes

This week, we’re again discussing findings presented during the Society of Gynecologic Oncology’s (SGO) Virtual 2021 Annual Meeting on Women’s Cancer. We’re hearing from three presenting authors on a number of topics, including maintenance olaparib for newly diagnosed advanced ovarian cancer; maintenance niraparib for platinum-sensitive ovarian cancer; and methods for reducing radiotherapy toxicity in patients with cervical cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

News From the Society of Gynecologic Oncology’s 2021 Annual Meeting on Women’s Cancer Mar 19, 2021

Show notes

The Society of Gynecologic Oncology’s virtual 2021 Annual Meeting on Women’s Cancer is taking place from March 19 to 25. This week, we’re hearing about findings presented at the meeting in endometrial and ovarian cancers.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Increase in Breast Cancer Diagnoses After Pandemic-Related Screening Interruptions Mar 12, 2021

Show notes

More than a year into the COVID-19 pandemic, researchers are beginning to examine the effects of the virus in the larger health-care sphere. This week, we’ll review a report on an observed increase of breast cancer diagnoses in Italy after pandemic-related screening interruptions. We’ll also discuss two FDA approvals that occurred over the past week for lymphoma and kidney cancer.

Coverage of stories discussed this week on ascopost.com:

Increase in Diagnosis of Node-Positive and Stage III Breast Cancer After Screening Interruption Due to the COVID-19 Pandemic

FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma

FDA Approves Tivozanib for Relapsed or Refractory Advanced Renal Cell Carcinoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Recent Regulatory Decisions in Multiple Myeloma and Lung Cancer Mar 08, 2021

Show notes

This week, we’re discussing recent regulatory decisions, ranging from FDA approvals in multiple myeloma and non–small cell lung cancer to the withdrawal of a widely used drug’s indication for small cell lung cancer.

Coverage of stories discussed this week on ascopost.com:

FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma

FDA Approves Lorlatinib for Metastatic ALK -Positive NSCLC

Pembrolizumab's Indication in Small Cell Lung Cancer Is Withdrawn

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Genitourinary Cancers Symposium: Immunotherapy for RCC, Neoadjuvant Therapy for Bladder Cancer Feb 26, 2021

Show notes

This week, we’re continuing our coverage of results presented at the 2021 Genitourinary Cancers Symposium, focusing on research findings in renal cell carcinoma and bladder cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.